The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers.
Atherly AJ, Camidge DR. The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers. Br J Cancer. 2012 Mar 13; 106(6):1100-6.